CEIX yields 0.59% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, CEIX + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CEIX + PFE for your $10,000?
CONSOL Energy Inc. produces and exports bituminous coal in the United States. It operates through PAMC, CONSOL Marine Terminal, and Other segments. The company engages in the mining, preparation, and marketing of bituminous coal to power generators, industrial end-users, and metallurgical end-users; and provision of coal export terminal services, as well as development of the Itmann Mine and the Greenfield reserves. It owns and operates the Pennsylvania Mining Complex (PAMC), which includes the Bailey Mine, the Enlow Fork Mine, the Harvey Mine, and the Central Preparation Plant; and CONSOL Marine Terminal located in the port of Baltimore. As of December 31, 2021, the company had 612.1 million tons of proven and probable coal reserves at PAMC. It also owns approximately 1.4 billion tons of Greenfield reserves located in the Northern Appalachian, Central Appalachian, and Illinois basins. The company was founded in 1860 and is headquartered in Canonsburg, Pennsylvania.
Full CEIX Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.